ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2129

Precipitating Anti-dsDNA Peptide Repertoires in Lupus

Jing Jing Wang1, Alexander Colella1, Dimitra Beroukas2, Tim Chataway3 and Tom Gordon1,4, 1Immunology, Flinders University, Adelaide, Australia, 2Immunology, SA Pathology, Adelaide, AR, Australia, 3Proteomic Facility, Flinders University, Adelaide, Australia, 4Immunology, SA Pathology, Adelaide, Australia

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: anti-dsDNA, immunoglobulin (IG) and proteomics, Lupus

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Anti-double-stranded (ds)DNA autoantibodies are prototypic serological markers of systemic lupus erythematosus (SLE) but little is known about their immunoglobulin variable (IgV) region composition at the level of the secreted (serum) proteome. Here, we use a novel proteomic workflow based on de novo database mass spectrometric sequencing of anti-dsDNA precipitins to analyse IgV subfamily expression and mutational signatures of high-affinity, precipitating anti-dsDNA responses.

Methods: Anti-dsDNA antibodies were purified from serum precipitins reactions prepared by agarose gel immunodiffusion between circular plasmid dsDNA and SLE serum from eight patients testing positive for anti-dsDNA by Farr radioimmunoassays (RIA). Microgram amounts of precipitating anti-dsDNA Igs were separated by SDS-PAGE, and in-gel tryptic and chymotryptic digests were performed on the heavy (H) and light (L)-chain bands and peptides were subjected to nano-high performance liquid chromatography-mass spectrometry followed by combined de novo amino acid sequencing and database matching using Peaks 8.0 software utilising ImMunoGeneTics (IMGT) and Uniprot databases. L-chain complementarity determining region 3 (CDR3) peptides were used as biomarkers to track serum anti-dsDNA clonotypes using quantitative multiple reaction monitoring (MRM).

Results: Serum anti-dsDNA proteomes were oligoclonal with shared (public) expression of IgG heavy chain variable region (IGHV) and kappa chain variable region (IGKV) subfamilies. IgV peptide maps from eight subjects showed extensive public and random (private) amino acid replacement mutations with prominent arginine substitutions across H- and L-chains. Shared sets of LCDR3 peptides specified by arginine substitutions were sequenced from the dominantly expressed IGKV3-20 subfamily, with changes in expression levels of a clonal L-chain CDR3 peptide by quantitative MRM paralleling the rise and fall of anti-dsDNA levels by Farr RIA. The heavily mutated IgV peptide signatures of precipitating anti-dsDNA autoantibody proteomes reflect the strong selective forces that shape humoral anti-dsDNA responses in germinal centres.

Conclusion: This first comprehensive proteomic analysis of precipitating anti-dsDNA IgV peptide repertoires in lupus serum offers a fresh approach for characterising and monitoring anti-dsDNA clonal populations with MS precision and accuracy, and for comparing their molecular signatures with other high-throughput “omics” technologies. Direct sequencing of agarose gel precipitins using microlitre volumes of stored sera streamlines the antibody sequencing workflow and is generalisable to other precipitating serum antibodies.


Disclosure: J. J. Wang, None; A. Colella, None; D. Beroukas, None; T. Chataway, None; T. Gordon, None.

To cite this abstract in AMA style:

Wang JJ, Colella A, Beroukas D, Chataway T, Gordon T. Precipitating Anti-dsDNA Peptide Repertoires in Lupus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/precipitating-anti-dsdna-peptide-repertoires-in-lupus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/precipitating-anti-dsdna-peptide-repertoires-in-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology